OG Flashcards
Decreasing order of mortality in neonates
Prematurity
Birth asphyxia
Sepsis
Congenital anomalies
Minimum antenatal visits
WHO recent - 8
WHO old - 4
GoI - 4
Anemia Mukt bharath
1) Mild to moderate - 7 to 10.9
a)<34 weeks → 2 IFA
i)Tolerates → continue
ii) not tolerate → IV Iron sucrose
b)>34 weeks → IV Iron sucrose
2) Severe - <7
a) 5 to 6.9
i)<34 weeks → IV Iron sucrose
ii)>34 weeks → Blood transfusion
b)<5 → Blood transfusion
Cervavac
Quadrivalent recombinent 6,11,16,18
L1 capsid
<15 yrs - 2 doses 0,6
>15 yrs - 3 doses 0,1,6
C/I - pregnancy
A/E - syncopal attack
WHO SAGE guidelines for cervical cancer vaccine
Gardasil 9 strains - 6,11,16,18,31,33,45,52,58
<21 yrs - 1 or 2 doses
>=21yrs - 2 doses
C/I for HRT
Stroke
Breast Ca
CAD
VTE
Active Liver disease
HRT risks
HRT is given in <60 yrs or <10 yrs from menopause
E+P - no effect on CAD & endometrial ca
E alone - ↓CAD & ↑ endometrial ca
OCP risks
↑ hepatic adenoma
↑ cervical ca
↑ breast ca (slight)
↓ ovarian ca
↓ endometrial ca
↓ colon ca
↓ benign breast disease
C/I for uterotonics
Carboprost - asthma
Methergine - PE/E/Heart disease
Estrogen in pregnancy
↑RAAS - ↑Aldosterone
Skin changes
↑TBG
↑Coagulation factors
Cholestasis
Surgery in uterine inversion
Huntingtons surgery
DMPA
150mg IM
Safe period 4 weeks
Return of fertility 1 year
Ovarian cancer
RF:
Infertility/nulliparity
PCOS
Endometriosis
Early menarche / late menopause
Protective factors:
OCPs
Breastfeeding
Pregnancy
M/c gene p53>BRCA
Ovarian cancer
RF:
Infertility/nulliparity
PCOS
Endometriosis
Early menarche / late menopause
Protective factors:
OCPs
Breastfeeding
Pregnancy
M/c gene p53>BRCA
Ovarian Tumors and markers
Leydig cell tumor - reinke crystals
Dysgerminoma - septa& lymphocytic infiltration
Krukenberg tumor - signet ring cells
Brenners - walthard cell nests
Chorio ca - dimorphic cyto and syncytiotrophoblasts
Endodermal sinus tumor - Schiller-duval bodies
Dermoid - rokitansky protruberance